Physio-Control, a wholly-owned subsidiary of Medtronic, has launched Version 4.1 of Lifenet System, a web-based platform designed to share emergent patient information between emergency medical services (EMS) and hospital care teams.
Physio-Control said that the latest release includes Lifenet Adapter, an interface between the Lifenet System and various manufacturers’ 12-lead management systems. Hospitals have the ability to standardize the management of chest pain cases regardless of the monitoring equipment used by EMS in the field improving both access to clinical information and operational efficiency.
The Lifenet System helps communities set up systems of care for patients experiencing ST-segment elevation myocardial infarction (STEMI), a type of heart attack.
Lifenet is designed to link time-critical transmission and alerts of a potential STEMI patient’s 12-lead ECG data from EMS to the awaiting hospital care team. While the patient is in transit, the hospital staff can review the patient’s baseline ECG report and status updates, determine where to route the patient, and whether to activate a catheterization laboratory.
According to Physio-Control, Version 4.1 introduces five new products, all developed in response to customer feedback which include Lifenet Adapter, Lifenet Connect, Lifenet Export, Lifenet Archive and Lifenet Asset.
Lifepak service and maintenance information can be downloaded to and accessible from the Lifenet System, allowing EMS personnel to spend less time on administrative duties and focus more on saving lives.
Lifenet System 4.1 operates on a secure, web-based platform and through subscription service so hospitals need not make a capital investment to benefit from this new technology.
Brian Webster, president of Physio-Control, said: “The Lifenet System was developed with the same focus and commitment to quality and innovation found in all our lifesaving devices. Our Lifenet System provides easy to use, reliable tools that help EMS and hospital care teams to accelerate their response, reduce time to treatment and potentially improve outcomes for their patients.”